CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guizhou Yibai Pharmaceutical Co., Ltd. Company Snapshot
Guizhou Yibai Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Yibai Pharmaceutical Co., Ltd. with three other companies in this sector in China: Hengkang Medical Group Co Ltd (2018 sales of 3.84 billion Chinese Renmimbi [US$548.51 million] of which 84% was Medical service), Jiangsu Kanion Pharmaceutical Co., Ltd. (3.82 billion Chinese Renmimbi [US$546.42 million] of which 100% was Domestic Sales of Industrial Enterprises), and Beijing Aosaikang Pharmaceutical Co Ltd (3.93 billion Chinese Renmimbi [US$561.87 million] of which 99% was Pharmaceutical manufacturing).

Sales Analysis. During the year ended December of 2018, sales at Guizhou Yibai Pharmaceutical Co., Ltd. were 3.88 billion Chinese Renmimbi (US$554.86 million). This is a very small increase of 2.0% versus 2017, when the company's sales were 3.81 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Guizhou Yibai Pharmaceutical Co., Ltd. (and since 2013, sales have increased a total of 39%). Sales of Medical Service saw an increase that was more than double the company's growth rate: sales were up 22.4% in 2018, from 718.51 million Chinese Renmimbi to 879.77 million Chinese Renmimbi. Not all segments of Guizhou Yibai Pharmaceutical Co., Ltd. experienced an increase in sales in 2018: sales of Medical Industry fell 3.1% to 2.99 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guizhou Yibai Pharmaceutical Co., Ltd.
  Stock Performance Chart for Guizhou Yibai Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 4.96
(Figures in Chinese Renmimbi)
1 Week 1.4%   13 Weeks 1.4%  
4 Weeks 7.4%   52 Weeks -19.7%  
 
Guizhou Yibai Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600594 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 3,882,863,179
(Year Ending Jan 2019).
Employees: 8,977
  Currency: Chinese Renmimbi Market Cap: 3,927,959,904
  Fiscal Yr Ends: December Shares Outstanding: 791,927,400
  Share Type: A Gu Closely Held Shares: 230,887,998
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.